慢性HBV携带者发展为肝细胞癌1例报告

刘丽莉; 齐月; 王丰姣; 胡月; 吕洋

doi:10.3969/j.issn.1001-5256.2016.05.033

慢性HBV携带者发展为肝细胞癌1例报告

DOI: 10.3969/j.issn.1001-5256.2016.05.033

1. 吉林大学第一医院肝胆胰内科
2. 吉林大学第一医院放射线科

基金项目:

中国肝炎防治基金会(CFHPC20131053)；

详细信息

中图分类号: R512.62;R735.7
计量
- 文章访问数: 1884
- HTML全文浏览量: 7
- PDF下载量: 413
- 被引次数: 0
出版历程
- 出版日期: 2016-05-20

A case of chronic hepatitis B virus carriers developing into hepatocellular carcinoma

Department of Hepatopancreatobiliary Medicine, The First Hospital of Jilin University

Research funding:

摘要

摘要:
<正>1病例资料患者男性,40岁,于1998年体检发现HBs Ag阳性,无乙型肝炎家族史,不饮酒,无其他疾病史,未行保肝及抗病毒治疗。2004年8月来本院门诊首次就诊,查血常规、凝血常规、肝功能均正常;HBs Ag、HBe Ag、抗-HBc阳性,HBV DNA定量6.3×105IU/ml,甲胎蛋白（AFP）3.65 ng/ml,腹部超声提示肝血管瘤可能性大,胆囊
- 肝炎病毒,乙型 /
- 癌,肝细胞 /
- 病例报告
- hepatitis B virus /
- carcinoma,hepatocellular /
- case reports

HTML全文

参考文献(15)

[1]YUEN MF,HOU JL,CHUTAPUTTI A.Hepatocelluar carcinoma in the Asia pacific region[J].J Gastroenterol Hepatol,2009,24(3):346-353.

[2]CHEN CJ,YU MW,LIAW YF.Epidemiological characteristics and risk factors of hepatocellular carcinoma[J].J Gastroenterol Hepatol,1997,12(9-10):s294-s308.

[3]BEASLEY RP.Hepatitis B virus as the etiological agent in hepatocellular carcinoma:epidemiological consideration[J].Hepatology,1982,2:21-26.

[4]PARK NH,CHUNG YH.Molecular mechanisms of hepatitis B virus-associated hepatocellular carcinoma[J].Korean J Hepatol,2007,13(3):320-340.

[5]McP ARTLAND JL,GUZAIL MA,KENDALL CH,et al.Apoptosis in chronic viral hepatitis parallels histological activity:an immunohistochemical investigation using anti-activated caspase-3 and M30 cytodeath antibody[J].Int J Exp Pathol,2005,68(1):19-24.

[6]LIU CJ,CHEN BF,CHEN PJ,et al.Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers[J].J Infect Dis,2006,193(9):1258-1265.

[7] LIAW YF,SUNG JJ,CHOW WC,et al.Lamivudine for patients with chronic hepatitis B and advanced liver disease[J].N Engl J Med,2004,351(15):1521-1531.

[8]SINGAL AK,SALAMEH H,KUO YF,et al.Meta-analysis:the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B[J].Aliment Pharmacol Ther,2013,38(2):98-106.

[9] Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B(2010 version)[J].J Clin Hepatol,2011,27(1):Ⅰ-ⅩⅥ.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010年版)[J].临床肝胆病杂志,2011,27(1):Ⅰ-ⅩⅥ.

[10]Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B:a 2015 update[J].J Clin Hepatol,2015,31(12):1941-1960.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015年更新版)[J].临床肝胆病杂志,2015,31(12):1941-1960.

[11]EL-SERAG HB.Epidemiology of viral hepatitis and hepatocellular carcinoma[J].Gastroenterology,2012,142(6):1264-1273.

[12]CHEN CF,LEE WC,YANG HI,et al.Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma[J].Gastroenterology,2011,141(4):1240-1248.

[13]PAPATHEODORIDIS GV,LAMPERTICO P,MANOLAKOPOULOS S,et al.Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy:a systematic review[J].J Hepatol,2010,53(2):348-356.

[14]MASUZAKI R,TATEISHI R,YOSHIDA H,et al.Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography[J].Hepatology,2009,49(6):1954-1961.

[15]XU WJ,GUO BL,HAN YG,et al.Diagnostic value of alpha-fetoprotein-L3 and Golgi protein 73 in hepatocellular carcinomas with low AFP levels[J].Tumour Biol,2014,35(12):12069-12074.

施引文献

资源附件(0)

访问统计